These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 6289586

  • 21. Persistent hypersecretion of ACTH in treated Addison's disease.
    Child DF, Lewis F, Williams CP.
    J R Soc Med; 1990 Jun; 83(6):399-400. PubMed ID: 2166161
    [No Abstract] [Full Text] [Related]

  • 22. [The necessity for perioperative cortisol substitution. Spontaneous and stimulated ACTH and cortisol secretion during unilateral adrenalectomy for renal cell carcinoma].
    Bischoff P, Noldus J, Harksen J, Bause HW.
    Anaesthesist; 1997 Apr; 46(4):303-8. PubMed ID: 9229984
    [Abstract] [Full Text] [Related]

  • 23. Gel chromatographic characterization of immunoreactive adrenocorticotropin in patients with ACTH hypersecretion.
    Reincke M, Allolio B, Deuss U, Winkelmann W.
    Klin Wochenschr; 1989 Nov 03; 67(21):1096-100. PubMed ID: 2555628
    [Abstract] [Full Text] [Related]

  • 24. The antiglucocorticoid and antiprogestin steroid RU 486 suppresses the adrenocorticotropin response to ovine corticotropin releasing hormone in man.
    Laue L, Chrousos GP, Loriaux DL, Barnes K, Munson P, Nieman L, Schaison G.
    J Clin Endocrinol Metab; 1988 Feb 03; 66(2):290-3. PubMed ID: 2828406
    [Abstract] [Full Text] [Related]

  • 25. Plasma ACTH and cortisol profiles in Addisonian patients receiving conventional substitution therapy.
    Scott RS, Donald RA, Espiner EA.
    Clin Endocrinol (Oxf); 1978 Dec 03; 9(6):571-6. PubMed ID: 218754
    [Abstract] [Full Text] [Related]

  • 26. Plasma immunoassayable ACTH levels during and after hydrocortisone infusion in patients with Cushing's disease.
    Hashimoto K, Takahara J, Hosogi H, Yunoki S, Ofuji T.
    Endocrinol Jpn; 1976 Jun 03; 23(3):243-9. PubMed ID: 186258
    [Abstract] [Full Text] [Related]

  • 27. Salivary Cortisol and Cortisone do not Appear to be Useful Biomarkers for Monitoring Hydrocortisone Replacement in Addison's Disease.
    Ross IL, Lacerda M, Pillay TS, Blom DJ, Johannsson G, Dave JA, Levitt NS, Haarburger D, van der Walt JS.
    Horm Metab Res; 2016 Dec 03; 48(12):814-821. PubMed ID: 27813051
    [Abstract] [Full Text] [Related]

  • 28. RADIOIMMUNOASSAY OF HUMAN PLASMA ACTH.
    YALOW RS, GLICK SM, ROTH J, BERSON SA.
    J Clin Endocrinol Metab; 1964 Nov 03; 24():1219-25. PubMed ID: 14230021
    [No Abstract] [Full Text] [Related]

  • 29. Hyper-adrenocorticotropinemia in a patient with Addison's disease after treatment with corticosteroids.
    Sugiyama K, Kimura M, Abe T, Ikezawa Y, Manaka H, Yamatani K, Tominaga M, Sasaki H, Misawa T.
    Intern Med; 1996 Jul 03; 35(7):555-9. PubMed ID: 8842762
    [Abstract] [Full Text] [Related]

  • 30. Studies on cortisol substitution therapy in patients with adrenal insufficiency.
    Nickelsen T, Schulz F, Demisch K.
    Exp Clin Endocrinol; 1983 Jul 03; 82(1):35-41. PubMed ID: 6311594
    [Abstract] [Full Text] [Related]

  • 31. Relationship of bioassayable and immunoassayable plasma ACTH and cortisol concentrations in normal subjects and in patients with Cushing's disease.
    Krieger DT, Allen W.
    J Clin Endocrinol Metab; 1975 Apr 03; 40(4):675-87. PubMed ID: 165214
    [Abstract] [Full Text] [Related]

  • 32. Probable ACTH-secreting pituitary tumour in association with Addison's disease.
    Yanase T, Sekiya K, Ando M, Nawata H, Kato K, Ibayashi H.
    Acta Endocrinol (Copenh); 1985 Sep 03; 110(1):36-41. PubMed ID: 2994336
    [Abstract] [Full Text] [Related]

  • 33. The effect of dexamethasone on the 24-hour profiles of adrenocorticotropin and cortisol in Cushing's syndrome.
    Refetoff S, Van Cauter E, Fang VS, Laderman C, Graybeal ML, Landau RL.
    J Clin Endocrinol Metab; 1985 Mar 03; 60(3):527-35. PubMed ID: 2982900
    [Abstract] [Full Text] [Related]

  • 34. Profound amplification of secretory-burst mass and anomalous regularity of ACTH secretory process in patients with Nelson's syndrome compared with Cushing's disease.
    van Aken MO, Pereira AM, van den Berg G, Romijn JA, Veldhuis JD, Roelfsema F.
    Clin Endocrinol (Oxf); 2004 Jun 03; 60(6):765-72. PubMed ID: 15163342
    [Abstract] [Full Text] [Related]

  • 35. Saliva cortisol measurement: simple and reliable assessment of the glucocorticoid replacement therapy in Addison's disease.
    Løvås K, Thorsen TE, Husebye ES.
    J Endocrinol Invest; 2006 Sep 03; 29(8):727-31. PubMed ID: 17033262
    [Abstract] [Full Text] [Related]

  • 36. Plasma immunoreactive corticotrophin and lipotrophin in Cushing's syndrome and Addison's disease.
    Gilkes JJ, Rees LH, Besser GM.
    Br Med J; 1977 Apr 16; 1(6067):996-8. PubMed ID: 192408
    [Abstract] [Full Text] [Related]

  • 37. Immunoglobulins of patients with idiopathic Addison's disease block the in vitro action of adrenocorticotropin.
    Wulffraat NM, Drexhage HA, Bottazzo GF, Wiersinga WM, Jeucken P, Van der Gaag R.
    J Clin Endocrinol Metab; 1989 Aug 16; 69(2):231-8. PubMed ID: 2546959
    [Abstract] [Full Text] [Related]

  • 38. A possible ACTH secreting tumour of the pituitary developing in a conventionally treated case of Addison's disease.
    Himsworth RL, Lewis JG, Rees LH.
    Clin Endocrinol (Oxf); 1978 Aug 16; 9(2):131-9. PubMed ID: 212238
    [Abstract] [Full Text] [Related]

  • 39. The effect of pulsatile human corticotropin-releasing hormone administration on the adrenal insufficiency that follows cure of Cushing's disease.
    Avgerinos PC, Nieman LK, Oldfield EH, Loughlin T, Barnes KM, Loriaux DL, Cutler GB.
    J Clin Endocrinol Metab; 1989 May 16; 68(5):912-6. PubMed ID: 2541160
    [Abstract] [Full Text] [Related]

  • 40. Normal and abnormal regulation of beta-msh in man.
    Abe K, Nicholson WE, Liddle GW, Orth DN, Island DP.
    J Clin Invest; 1969 Aug 16; 48(8):1580-5. PubMed ID: 4307702
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.